相关实验视频
Updated: Jun 20, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
429
[乳糖在癌症中的作用和机制]
Qicheng Zhang1, Limin Cao1, Ke Xu1
1Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|July 19, 2024
概括
乳糖化是一种与乳酸相关的新型蛋白质修饰,在癌症进展和免疫抑制中起着关键作用. 了解乳化为联合癌症治疗提供了新的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 翻译后修改 (PTMs) 改变蛋白质功能,影响细胞生物学和疾病.
- 乳化是一种涉及乳酸的新型PTM,它影响着基因组蛋白和非基因组蛋白.
- 乳化将新陈代谢重编程与表观遗传修饰联系起来.
研究的目的:
- 审查乳化在癌症进展中的多方面的作用.
- 探索乳酸化对瘤微环境相互作用和免疫抑制的影响.
- 确定癌症治疗和组合策略的新型分子标.
主要方法:
- 对癌症中乳化现有研究的文献综述.
- 分析证据,将乳化与瘤进展和预后联系起来.
- 综合了乳糖化对基因表达和药物耐药性的影响的数据.
主要成果:
- 乳糖化与促进瘤进展和免疫抑制有关.
- 希斯酸乳化会影响瘤和免疫细胞中的基因表达.
- 非希斯蛋白乳酸化会影响瘤的进展和药物耐药性.
结论:
- 乳化是癌症发展和进展的一个重要因素.
- 向乳化可能为癌症治疗提供新的治疗途径.
- 对乳糖的进一步研究可能会导致新的联合疗法,包括免疫疗法.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

